Back

Temporal trends in the utilization of heart failure medical therapy in LVAD-supported advanced heart failure patients: a single center experience

11 May 2024 (09:00 - 10:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - treatment 1 Ventricular Assist Devices HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Gregor Poglajen

University Medical Centre of Ljubljana, Ljubljana (Slovenia)

7 More presentations in this session

Presentation thumbnail
Effect of intra-aortic balloon pump support in right ventricular function in heart failure candidates for left ventricular assist device implantation and the prognostic role of interstitial fibrosis
Doctor M. Bonios (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Unraveling mortality predictors in continuous flow left ventricular assist device implantation: an in-depth analysis
Mr D. Verikas (Kaunas, LT)
Abstract Slides Video
Presentation thumbnail
A 4-year in-hospital mortality and renal infarction trends after left ventricular assist device implantation from 2017 to 2020
Doctor J. Perry (Brooklyn, US)
Abstract Slides Video
Presentation thumbnail
In-hospital bowel ischemia and mortality trends after cardiac output devices implantation in the USA from 2017 to 2020
Doctor J. Perry (Brooklyn, US)
Abstract Slides Video
Presentation thumbnail
Comparative analysis of ischaemic and dilated cardiomyopathy patients undergoing heartmate 3 implantation: insights from a tertiary hospital cohort
Mr D. Verikas (Kaunas, LT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - treatment 1

The Event

Event poster

Heart Failure 2024

11 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic importance of guideline-directed medical therapy after left ventricular assist devices: a 10-year single-centre experience
thumbnail
Congress Presentation
Can heart failure guideline-directed medical therapy improve left ventricular assist device outcomes?
thumbnail
Congress Presentation
All LVAD patients must be treated with guideline-directed medical therapy: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources